TRB Chemedica Competitors and Similar CompaniesClear all
TRB Chemedica's competitors and similar companies include Cosmo Pharmaceuticals, Repligen, Adamed and Swedish Orphan Biovitrum.
 TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices. |  Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy. |  Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. |  Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. | ||
Founding Date | Founding Date 1980 | Founding Date 1997 | Founding Date 1981 | Founding Date 1986 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more | Locations Dublin, IE HQ | Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more | ||
Employees | Employees 900 | Employees 339 | Employees 1,78312% decrease | Employees 1,515 | Employees 1,814 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) N/A | Valuation ($) 11.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €92.8m (FY, 2023) | Revenue (est.) $638.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) kr22.1b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods €21.8m (FY, 2023) | Cost of goods $353.9m (FY, 2023) | Cost of goods N/A | Cost of goods kr4.9b (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit €72.5m (FY, 2023) | Gross profit $284.8m (FY, 2023) | Gross profit N/A | Gross profit kr17.2b (FY, 2023) |
Net income | Net income N/A | Net income (€4.7m) (FY, 2023) | Net income $41.6m (FY, 2023) | Net income N/A | Net income kr2.4b (FY, 2023) |
Operating ⚠ | |||||
Trademarks (US) | Trademarks (US) 2 (Jun, 2020) | Trademarks (US) N/A | Trademarks (US) 12 (FY, 2017) | Trademarks (US) N/A | Trademarks (US) N/A |
For sources of this data, please see the company profile
View Company Profiles
Cosmo Pharmaceuticals
HQ
Dublin, IE
Employees
339
Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.
View companyRepligen
HQ
Waltham, US
Employees
1,783↓ 12% decrease
Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.
View companySwedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,814
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View company